Find below videos and webinars on AL amyloidosis. Click here to check full educational resources materials for all areas of work: myeloma and AL amyloidosis, access, patient evidence and capacity building and advocacy.
Masterclass 2024 | Shared decision-making

Now Playing
Masterclass 2024 | Shared decision-making
Summary of the session "Shared decision-making: improving effective ...
Summary of the session "Shared decision-making: improving effective communication between the patient and the medical team", given by Silene Ten Seldam, Research Assistant at MPE, during the MPE Masterclass, in ...May 2024.[+] Show More

Now Playing
MPE Masterclass 2024 | Actualización de los tratamientos del mieloma y la amiloidosis AL
Resumen de la charla ofrecida por el Dr. Albert Oriol (ICO) durante la ...
Resumen de la charla ofrecida por el Dr. Albert Oriol (ICO) durante la Masterclass de Myeloma Patients Europe (MPE) que tuvo lugar en Madrid en mayo de 2024.

Now Playing
Masterclass 2024 | Side effects and management of myeloma and AL amyloidosis treatments
Summary of the session "Side effects and management of myeloma and AL ...
Summary of the session "Side effects and management of myeloma and AL amyloidosis treatments" given by Dr. Charlotte Pawlyn, Haematologist and Clinician Scientist, Cancer Research UK, at the MPE Masterclass ...2024, held in Madrid, Spain.[+] Show More

Now Playing
MPE Masterclass 2024 | Myeloma and AL amyloidosis treatment updates
Summary of the session on myeloma and AL amyloidosis treatment updates ...
Summary of the session on myeloma and AL amyloidosis treatment updates given by Dr Albert Oriol, Head of the Clinical Research Unit, Institut Català d’Oncologia (ICO), held in May 2024 ...in Madrid, Spain[+] Show More

Now Playing
Myeloma and AL Amyloidosis European Clinical Trial Navigator
The Myeloma and AL Amyloidosis European Clinical Trial Navigator is an ...
The Myeloma and AL Amyloidosis European Clinical Trial Navigator is an online search tool to learn about and find clinical trials for myeloma, monoclonal gammopathy of undetermined significance (MGUS), smouldering ...multiple myeloma (SMM) and AL amyloidosis in Europe. With this tool, MPE wants to facilitate the search of clinical trials for these conditions and provide to patients, carers and advocates a patient-friendly tool not only to find clinical trials but also to know about their availability and location
for more information, head to our website: http://www.mpeurope.org[+] Show More
for more information, head to our website: http://www.mpeurope.org[+] Show More

Now Playing
The MPE clinical trial Navigator
The Myeloma and AL Amyloidosis European Clinical Trial Navigator is an ...
The Myeloma and AL Amyloidosis European Clinical Trial Navigator is an online search tool to learn about and find clinical trials for myeloma, monoclonal gammopathy of undetermined significance (MGUS), smouldering ...multiple myeloma (SMM) and AL amyloidosis in Europe. With this tool, MPE wants to facilitate the search of clinical trials for these conditions and provide to patients, carers and advocates a patient-friendly tool not only to find clinical trials but also to know about their availability and location
for more information, head to our website: http://www.mpeurope.org[+] Show More
for more information, head to our website: http://www.mpeurope.org[+] Show More

Now Playing
MPE webinar | AL amyloidosis treatment updates and patient experiences
Recording of the webinar “AL amyloidosis treatment updates and patient ...
Recording of the webinar “AL amyloidosis treatment updates and patient experiences on new therapies” held by MPE on Tuesday 16 April 2024.
The webinar was given by Dr. Moshe Gatt, ...Physician Researcher Haematologist at the Hebrew University of Jerusalem, Israel, along with two AL Amyloidosis patients from Israel, Naphtali Mastboim and Melvin Granatstein, who shared their experiences with new therapies like CAR-T and CAEL-101.[+] Show More
The webinar was given by Dr. Moshe Gatt, ...Physician Researcher Haematologist at the Hebrew University of Jerusalem, Israel, along with two AL Amyloidosis patients from Israel, Naphtali Mastboim and Melvin Granatstein, who shared their experiences with new therapies like CAR-T and CAEL-101.[+] Show More

Now Playing
ASH 2023 | AL amyloidosis highlights
Prof. Monique Minnema, internist and haematologist at Academic Medical ...
Prof. Monique Minnema, internist and haematologist at Academic Medical Center, Amsterdam and the University Medical Center, Utrecht, The Netherlands, explains the most important updates on AL amyloidosis presented at ASH ...2023.[+] Show More

Now Playing
ASH 2023 | HBI0101 therapy: CAR-T in AL amyloidosis
In this video, Dr. Moshe Gatt, Department of Haematology, Hebrew ...
In this video, Dr. Moshe Gatt, Department of Haematology, Hebrew University of Jerusalem, Israel, explains the latest findings of the HBI0101 therapy for AL amyloidosis patients presented at ASH 23.

Now Playing
EHA 2023 | EMN 27: Belantamab mafodotin in relapsed or refractory AL Amyloidosis patients
Interview filmed with Dr. Efstathios Kastritis, Associate Professor at ...
Interview filmed with Dr. Efstathios Kastritis, Associate Professor at the National and Kapodistrian University of Athens, Greece, to summarise the results of the clinical trial EMN 27, presented at European ...Hematology Association’s annual congress (EHA 2023 Virtual), held in June 2023.[+] Show More

Now Playing
Masterclass 2023 | Myeloma and AL amyloidosis treatment updates
Prof. Dr. Moshe Gatt, Director, Hematology Department, Hadassah Hebrew ...
Prof. Dr. Moshe Gatt, Director, Hematology Department, Hadassah Hebrew University Medical Center, Jerusalem, explains the latest updates on myeloma and AL amyloidosis treatments at the MPE Masterclass 2023 in Dubrovnik, ...Croatia.[+] Show More

Now Playing
Masterclass 2023 | CAR-T updates, challenges, and the future
Dr. Charlotte Pawlyn, PhD, Haematologist and Clinician Scientist, The ...
Dr. Charlotte Pawlyn, PhD, Haematologist and Clinician Scientist, The Institute of Cancer Research, London, explains the latest updates on CAR-T in myeloma and AL amyloidosis at the MPE Masterclass 2023 ...in Dubrovnik, Croatia.[+] Show More

Now Playing
ASH 22 | CAR T-cell therapy in AL amyloidosis
Professor Efstathios Kastritis, Associate Professor at the National ...
Professor Efstathios Kastritis, Associate Professor at the National and Kapodistrian University of Athens, Athens, Greece, and member of the Myeloma Patients Europe (MPE) Medical Advisory Committee, explains if CAR T-cell ...therapy is being explored for the treatment of AL amyloidosis.[+] Show More

Now Playing
ASH 22 | AL amyloidosis highlights
Professor Efstathios Kastritis, Associate Professor at the National ...
Professor Efstathios Kastritis, Associate Professor at the National and Kapodistrian University of Athens, Athens, Greece, explains the main AL amyloidosis highlights presented at ASH 2022.

Now Playing
EHA 2022 | AL amyloidosis updates
Interview filmed with Dr Paolo Milani, to summarise the main updates ...
Interview filmed with Dr Paolo Milani, to summarise the main updates on AL amyloidosis presented at the EHA 2022 hybrid congress.
1
of 4